Renaissance Technologies - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 176 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.51 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$2,643,000
-46.0%
131,100
-0.1%
0.00%
-50.0%
Q2 2021$4,896,000
+29.7%
131,200
-11.1%
0.01%
+20.0%
Q1 2021$3,775,000
-75.1%
147,645
-78.5%
0.01%
-68.8%
Q4 2020$15,132,000
-26.7%
686,878
-40.2%
0.02%
-23.8%
Q3 2020$20,651,000
-10.7%
1,147,900
+26.1%
0.02%
+5.0%
Q2 2020$23,119,000
+65.8%
910,200
+19.9%
0.02%
+42.9%
Q1 2020$13,945,000
-36.2%
759,100
-23.5%
0.01%
-17.6%
Q4 2019$21,863,000
+213.7%
992,400
+104.4%
0.02%
+183.3%
Q3 2019$6,970,000
+91.6%
485,400
+34.6%
0.01%
+200.0%
Q2 2018$3,638,000
+31.5%
360,500
+24.6%
0.00%
-33.3%
Q1 2018$2,767,000
-45.3%
289,400
-48.3%
0.00%
-50.0%
Q4 2017$5,060,000
+87.4%
560,300
+19.3%
0.01%
+100.0%
Q3 2017$2,700,000
+92.2%
469,600
+6.0%
0.00%
+50.0%
Q2 2017$1,405,000
-1.3%
443,100
+5.9%
0.00%0.0%
Q1 2017$1,423,000
+20.9%
418,500
+2.4%
0.00%0.0%
Q4 2016$1,177,000
-38.2%
408,682
+26.1%
0.00%
-33.3%
Q3 2016$1,905,000
+739.2%
324,000
+328.6%
0.00%
Q2 2016$227,000
+41.9%
75,600
+152.8%
0.00%
Q1 2016$160,000
-81.4%
29,900
-51.5%
0.00%
-100.0%
Q2 2015$861,000
+184.2%
61,700
+389.7%
0.00%
+100.0%
Q1 2015$303,00012,6000.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 2,062,991$7,014,0001.85%
RA Capital Management 2,428,571$8,257,0001.01%
Omega Fund Management, LLC 223,457$760,0000.49%
683 Capital Management, LLC 800,000$2,720,0000.42%
EcoR1 Capital, LLC 382,000$1,299,0000.33%
Eventide Asset Management 377,000$1,282,0000.08%
Palo Alto Investors LP 481,519$1,637,0000.08%
SABBY MANAGEMENT, LLC 200,000$680,0000.04%
BOURGEON CAPITAL MANAGEMENT LLC 13,500$46,0000.03%
Quotient Investors, LLC 13,600$46,0000.03%
View complete list of DICERNA PHARMACEUTICALS INC shareholders